Life Science

Before researchers can make scientific breakthroughs, they need state-of-the-art tools, services and expertise to perform experiments and engineer new products. At MilliporeSigma, that’s where we come in.

Our Life Science business accelerates access to health for people everywhere.

We provide infinite solutions to solve the toughest problems in life science in collaboration with the global scientific community. Our tools, services and digital platforms empower scientists and engineers at every stage, helping deliver breakthrough therapies more quickly.

To learn more about our portfolio offerings, please visit


Before researchers can make scientific breakthroughs, they must have access to state-of-the-art tools, services and expertise to perform experiments and engineer new products. This is where we begin our journey of collaboration with customers in academia, biomanufacturing and testing. Learn more about our roles in:

Life Science by the numbers

  • 59

    manufacturing sites around the globe.

  • 100+

    distribution centers worldwide.

  • 21k+


  • 300k+


Helping to Fight Covid-19

  • As a global life science supplier, we are here to help in the response to COVID-19.
  • From supplying raw materials and research products for detection and characterization to production, we’ve consolidated relevant product and service offerings within a centralized COVID-19 webpage.
  • Current events around the spread of COVID-19 and its impact on public health continue to evolve. We're tracking the latest news and updates related to our role in COVID-19 response efforts.

Related News

View All News
  1. Press Releases

    MilliporeSigma Announces Expanded Partnership with Beyond Benign to Increase ...

    MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, has entered an expanded partnership with global green chemistry education nonprofit Beyond Benign.


  2. Press Releases

    Merck KGaA, Darmstadt, Germany, First Company to Offer Open-Source Library ...

    Merck KGaA, Darmstadt, Germany has launched its open-source code library around Palantir Foundry on GitHub®.


  3. Press Releases

    MilliporeSigma Signs MoU with Synplogen to Accelerate Development and Manufacturing ...

    MilliporeSigma has signed a non-binding Memorandum of Understanding (MoU) with Synplogen, a startup spun out of Kobe University's Graduate School of Science, Technology and Innovation.


M Lab™ Collaboration Center

  • Our M Lab™ Collaboration Centers offer vibrant collaboration spaces in which our customers can explore ideas, learn innovative techniques, and work side by side with our scientists and engineers to solve critical process development challenges.
  • This global network of non-GMP labs, designed specifically for customers, offer the flexibility to troubleshoot and test in our facility without impacting your production line.
  • Located in key biopharma hubs around the world, our experts are ready to collaborate with your experts to solve your toughest problems - together.
M Labs™ Overview

What M Lab™ Collaboration Centers have to Offer?

At the M Lab™ Collaboration Centers, no challenge is too great. Our technical expertise spans all aspects of the process train.

We offer:

  • Pilot lab and process development labs
  • Interactive digital tools & Curiosity Hub
  • Hands-on and classroom setting training

Learn more